John F. Paolini Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

John F. Paolini is CHIEF MEDICAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 52,038 shares of KNSA, which is worth approximately $1.07 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 60,692 shares (Class A Ordinary Share) at a price of $26.61 per share, resulting in proceeds of $1,615,014. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52K

0% 3M change

15.92% 12M change

Total Value Held $1.07 Million

John F. Paolini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Open market or private sale	$1,615,014 $26.61 p/Share	60,692 Reduced 53.84%	52,038 Class A Ordinary Share
Sep 03 2024	BUY Exercise of conversion of derivative security	$171,758 $2.83 p/Share	60,692 Added 35.0%	112,730 Class A Ordinary Share
Sep 02 2024	SELL Payment of exercise price or tax liability	$22,327 $26.74 p/Share	835 Reduced 1.58%	52,038 Class A Ordinary Share
Sep 02 2024	BUY Exercise of conversion of derivative security	-	1,725 Added 3.16%	52,873 Class A Ordinary Share
Sep 01 2024	SELL Payment of exercise price or tax liability	$53,319 $26.74 p/Share	1,994 Reduced 3.75%	51,148 Class A Ordinary Share
Sep 01 2024	BUY Exercise of conversion of derivative security	-	4,121 Added 7.2%	53,142 Class A Ordinary Share
Jul 23 2024	SELL Open market or private sale	$584,980 $26.59 p/Share	22,000 Reduced 31.52%	47,803 Class A Ordinary Share
Jul 23 2024	BUY Exercise of conversion of derivative security	$40,920 $1.86 p/Share	22,000 Added 23.96%	69,803 Class A Ordinary Share
Apr 08 2024	SELL Payment of exercise price or tax liability	$13,120 $17.9 p/Share	733 Reduced 1.51%	47,803 Class A Common Share
Apr 08 2024	BUY Exercise of conversion of derivative security	-	2,497 Added 4.89%	48,536 Class A Common Share
Apr 01 2024	SELL Payment of exercise price or tax liability	$9,396 $19.7 p/Share	477 Reduced 1.03%	46,039 Class A Common Share
Apr 01 2024	BUY Exercise of conversion of derivative security	-	1,624 Added 3.37%	46,516 Class A Common Share
Mar 01 2024	SELL Open market or private sale	$410,233 $21.77 p/Share	18,844 Reduced 29.57%	44,892 Class A Common Share
Mar 01 2024	BUY Exercise of conversion of derivative security	$35,049 $1.86 p/Share	18,844 Added 23.1%	62,736 Class A Common Share
Feb 27 2024	SELL Open market or private sale	$213,580 $21.03 p/Share	10,156 Reduced 18.45%	44,892 Class A Common Share
Feb 27 2024	BUY Exercise of conversion of derivative security	$18,890 $1.86 p/Share	10,156 Added 15.58%	55,048 Class A Common Share
Dec 07 2023	SELL Open market or private sale	$505,934 $17.69 p/Share	28,600 Reduced 38.92%	44,892 Class A Common Share
Dec 07 2023	BUY Exercise of conversion of derivative security	$53,196 $1.86 p/Share	28,600 Added 28.01%	73,492 Class A Common Share
Sep 05 2023	SELL Open market or private sale	$7,012 $17.53 p/Share	400 Reduced 0.88%	44,892 Class A Common Share
Sep 05 2023	BUY Exercise of conversion of derivative security	$744 $1.86 p/Share	400 Added 0.88%	45,292 Class A Common Share
Sep 02 2023	SELL Payment of exercise price or tax liability	$9,004 $17.76 p/Share	507 Reduced 1.12%	44,892 Class A Common Share
Sep 02 2023	BUY Exercise of conversion of derivative security	-	1,725 Added 3.66%	45,399 Class A Common Share
Sep 01 2023	SELL Payment of exercise price or tax liability	$13,035 $17.76 p/Share	734 Reduced 1.65%	43,674 Class A Common Share
Sep 01 2023	BUY Exercise of conversion of derivative security	-	2,498 Added 5.33%	44,408 Class A Common Share
Jul 25 2023	SELL Open market or private sale	$550,420 $18.98 p/Share	29,000 Reduced 40.9%	41,910 Class A Common Share

JFP

John F. Paolini

CHIEF MEDICAL OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account